With a yearly budget of nearly $48 billion, the NIH is the world’s largest public funder of biomedical research. The agency's ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

Biotech firm Phytome Life Sciences plans to establish a headquarters in Saudi Arabia in a bid to accelerate commercialization ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...

Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes ...

Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and ...

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...